Novel Monoclonal Antibodies for Studies of Human and Rhesus Macaque Secretory Component and Human J-Chain

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Volumn 35, Issue 4, 2016, Pages 217-226

  Zhang, Ruijun ^a   Munir Alam, S ^a   Yu, Jae Sung ^a   Scearce, Richard ^a   Lockwood, Bradley ^a   Hwang, Kwan Ki ^a   Parks, Robert ^a   Permar, Sallie ^a   Brandtzaeg, Per ^b   Haynes, Barton F ^a   Liao, Hua Xin ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN J CHAIN; MONOCLONAL ANTIBODY; SECRETORY COMPONENT; IMMUNOGLOBULIN STRUCTURE; SECRETORY IMMUNOGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; HUMAN; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PLASMA CELL; PLASMABLAST; PRIORITY JOURNAL; RHESUS MONKEY; WESTERN BLOTTING; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CROSS REACTION; IMMUNOGLOBULIN STRUCTURE; IMMUNOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CROSS REACTIONS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN JOINING REGION; MACACA MULATTA; MICE;

EID: 85018193253     PISSN: None     EISSN: 21679436     Source Type: Journal    
DOI: 10.1089/mab.2016.0014     Document Type: Article

References (54)

1. Brandtzaeg P: Secretory IgA: Designed for anti-microbial defense. Front Immunol 2013;4:222.
2. Brandtzaeg P, Kiyono H, Pabst R, and Russell MW: Terminology: Nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 2008;1:31-37.
3. Fagarasan S, and Honjo T: Intestinal IgA synthesis: Regulation of front-line body defences. Nat Rev Immunol 2003;3: 63-72.
4. Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, and Phalipon A: Anti-inflammatory role for intracellular dimeric immunoglobulin A by neutralization of lipopolysaccharide in epithelial cells. Immunity 2003;18: 739-749.
5. Macpherson AJ, and Uhr T: Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004;303:1662-1665.
6. Peterson DA, McNulty NP, Guruge JL, and Gordon JI: IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007;2:328-339.
7. Suzuki K, Meek B, Doi Y, Muramatsu M, Chiba T, Honjo T, et al. : Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci U S A 2004;101:1981-1986.
8. Battle-Miller K, Eby CA, Landay AL, Cohen MH, Sha BE, and Baum LL: Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1-Infected women. J Infect Dis 2002;185:439-447.
9. Blutt SE, and Conner ME: The gastrointestinal frontier: IgA and viruses. Front Immunol 2013;4:402.
10. Blutt SE, Miller AD, Salmon SL, Metzger DW, and Conner ME: IgA is important for clearance and critical for protection from rotavirus infection. Mucosal Immunol 2012;5: 712-719.
11. Golby SJ, and Spencer J: Where do IgA plasma cells in the gut come from Gut 2002;51:150-151.
12. Renegar KB, Small PA, Jr, Boykins LG, and Wright PF: Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 2004; 173:1978-1986.
13. Slack E, Balmer ML, Fritz JH, and Hapfelmeier S: Functional flexibility of intestinal IgA-Broadening the fine line. Front Immunol 2012;3:100.
14. Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, et al. : Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 2012;366: 1275-1286.
15. Brandtzaeg P: The mucosal B-cell system. In: Mucosal Immunology, 4th ed. Mestecky J, Strober W, Russell MW, KelsallBL, CheroutreH, and LambrechtBN(eds.), Academic Press/Elsevier, Amsterdam, 2015, Chapter 31, pp. 623-681.
16. Wycoff KL: Secretory IgA antibodies from plants. Curr Pharm Des 2005;11:2429-2437.
17. Brandtzaeg P: Mucosal and glandular distribution of immunoglobulin components: Differential localization of free and bound SC in secretory epithelial cells. J Immunol 1974;112:1553-1559.
18. Brandtzaeg P, and Prydz H: Direct evidence for an integrated function of J-chain and secretory component in epithelial transport of immunoglobulins. Nature 1984;311:71-73.
19. Mostov KE, Friedlander M, and Blobel G: The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains. Nature 1984;308:37-43.
20. Brandtzaeg P: Presence of J-chain in human immunocytes containing various immunoglobulin classes. Nature 1974; 252: 418-420.
21. Johansen F-E, Pekna M, Norderhaug IN, Haneberg B, Hietala MA, Krajci P, Betsholtz C, and Brandtzaeg P: Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med 1999;190:915-921.
22. Quan CP, Berneman A, Pires R, Avrameas S, and Bouvet JP: Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 1997;65:3997-4004.
23. Corthesy B: Recombinant secretory immunoglobulin A in passive immunotherapy. Curr Pharm Biotechnol 2003;4: 51-67.
24. Fukuyama Y, King JD, Kataoka K, Kobayashi R, Gilbert RS, Oishi K, et al. : Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae. J Immunol 2010;185:1755-1762.
25. Brandtzaeg P: Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007;25:5467-5484.
26. Ambrose CS, Wu X, Jones T, and Mallory RM: The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine 2012;30:6794-6801.
27. Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, et al. : Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 2000;181:1133-1137.
28. Weintraub JA, Hilton JF, White JM, Hoover CI, Wycoff KL, Yu L, et al. : Clinical trial of a plant-derived antibody on recolonization of mutans streptococci. Caries Res 2005;39:241-250.
29. Mantis NJ, Palaia J, Hessell AJ, Mehta S, Zhu Z, Corthesy B, et al. : Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12V region. J Immunol 2007;179:3144-3152.
30. Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, et al. : Complete sequencing and characterization of 21, 243 full-length human cDNAs. Nat Genet 2004;36:40-45.
31. Sunagawa K, Omagari D, Nishiyama M, Asano M, Okudera M, Sugitani M, et al. : Distinct functional regions of the human polymeric immunoglobulin receptor. Scand J Immunol 2013;78:339-344.
32. Chintalacharuvu KR, and Morrison SL: Production of secretory immunoglobulin A by a single mammalian cell. Proc Natl Acad Sci U S A 1997;94:6364-6368.
33. Liao HX, Bonsignori M, Alam SM, McLellan JS, Tomaras GD, Moody MA, et al. : Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity 2013;38:176-186.
34. de Koning-Ward TF, Fidock DA, Thathy V, Menard R, van Spaendonk RM, Waters AP, et al. : The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome. Mol Biochem Parasitol 2000;106:199-212.
35. Ng SK: Generation of high-expressing cells by methotrexate amplification of destabilized dihydrofolate reductase selection marker. Methods Mol Biol 2012;801:161-172.
36. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, et al. : Generation and initial analysis of more than 15, 000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A 2002;99:16899-16903.
37. Bonsignori M, Hwang KK, Chen X, Tsao CY, Morris L, Gray E, et al. : Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J Virol 2011;85:9998-10009.
38. Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, et al. : Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 2011;333:1593-1602.
39. Santra S, Tomaras GD, Warrier R, Nicely NI, Liao HX, Pollara J, et al. : Human non-neutralizing HIV-1 envelope monoclonal antibodies limit the number of founder viruses during SHIV mucosal infection in rhesus macaques. PLoS Pathog 2015;11:e1005042.
40. Moody MA, Amos J, Gurley TC, Drinker M, Luney KD, Marshall D, et al. : Isolation of human monoclonal antibodies from HIV-uninfected subjects immunized with gp120/Nef-Tat/AS01B by dual-color antigen-specific B cell sorting. AIDS Res Hum Retroviruses 2010;26(Suppl):26:OA05.
41. Whittle JR, Zhang R, Khurana S, King LR, Manischewitz J, Golding H, et al. : Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A 2011;108:14216-14221.
42. Moldt B, Saye-Francisco K, Schultz N, Burton DR, and Hessell AJ: Simplifying the synthesis of SIgA: Combination of dIgA and rhSC using affinity chromatography. Methods 2014;65:127-132.
43. Tey BT, and Al-Rubeai M: Effect of Bcl-2 overexpression on cell cycle and antibody productivity in chemostat cultures of myeloma NS0 cells. J Biosci Bioeng 2005;100:303-310.
44. Tey BT, Singh RP, Piredda L, Piacentini M, and Al-Rubeai M: Influence of bcl-2 on cell death during the cultivation of a Chinese hamster ovary cell line expressing a chimeric antibody. Biotechnol Bioeng 2000;68:31-43.
45. Scearce RM, and Eisenbarth GS: Production of monoclonal antibodies reacting with the cytoplasm and surface of differentiated cells. Methods Enzymol 1983;103:459-469.
46. Brandtzaeg P: Purification of J-chain after mild reduction of human immunoglobulins. Scand J Immunol 1975;4:309-320.
47. Ma B-J, Alam SM, Go EP, Lu X, Desaire H, Tomaras GM, et al. : Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. PLoS Pathog 2011;7:e1002200.
48. Liao HX, Sutherland LL, Xia SM, Brock ME, Scearce RM, Vanleeuwen S, et al. : A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. Virology 2006;353:268-282.
49. Janeway C, Travers P, Walport M, and Shlomckik J: Immunobiology: Immune System in Health and Disease, 5th ed. Garland Science, New York, 2001.
50. Liao HX, LevesqueMC, Nagel A, Dixon A, Zhang R, Walter E, et al. : High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods 2009;158:171-179.
51. Brandtzaeg P: Human secretory immunoglobulins. V. Occurrence of secretory piece in human serum. J Immunol 1971;106:318-323.
52. Brandtzaeg P: Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology 1974;26:1101-1114.
53. Brandtzaeg P and Rognum TO: Evaluation of nine different fixatives. 1. Preservation of immunoglobulin isotypes, J chain, and secretory component in human tissues. Pathol Res Pract 1984;179:250-266.
54. Fasching CE, Grossman T, Corthesy B, Plaut AG, Weiser JN, and Janoff EN: Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae. Infect Immun 2007;75:1801-1810.